RNA editing is the next frontier in gene therapy – here’s what you need to know
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. This trial marks a new (...)
Site référencé: Raw Story
Raw Story
'On biblical grounds, sit this one out' : Illinois governor roasts Ken Paxton with comeback
14/08/2025
'No, denied !' Expert mocks Ken Paxton as 'Mickey Mouse civil warrant' blows up in his face
14/08/2025
Economist Paul Krugman coins two-word phrase to sum up Trump’s hiring playbook
14/08/2025
NYT's Maggie Haberman unmasks Trump's new ploy to exert 'different kind of control'
14/08/2025
'Enormous deal' : Legal expert warns Supreme Court telegraphed its next 'inexcusable' move
14/08/2025
MAGA candidate raises eyebrows by blowing off key debate : 'Not sure what the strategy is'
14/08/2025
